Skip to content

Management of Malignant Intraductal Papillary Mucinous Neoplasm With Mucinous Ascites: Case Series

Management of Malignant Intraductal Papillary Mucinous Neoplasm With Mucinous Ascites: Case Series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190704001
Enrollment
Unknown
Registered
2019-07-04
Start date
2008-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with pancreatic cystic tumor Patient who received cytoreductive surgery and HIPEC Pancreatic Cystic Tumor Intraductal papillary mucinous neoplasm Pseudomyxoma peritoneii HIPEC Cytoreductive Surgery

Interventions

&#45
Treatment

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patient with pancreatic cystic tumor Patient who received cytoreductive surgery and HIPEC

Exclusion criteria

Exclusion criteria: Patient who denial, not fit for surgery

Design outcomes

Primary

MeasureTime frame
Survival outcome - -

Secondary

MeasureTime frame
- - -

Countries

Japan

Contacts

Public ContactChayanit Sirisai

National cancer institute of Thailand

schanyt@gmail.com+66826966599

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026